GlassScriptPhysician profile
Supriya Jain
NPI 1639597529
$743.96
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.64 · 2020: $92.23 · 2021: $108 · 2022: $117 · 2023: $171 · 2024: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $216.38 | 2024 | |
| Siemens Medical Solutions USA, INC. | $171.22 | 2023 | |
| Amgen INC. | $59.46 | 2021 | |
| Viewray Technologies INC | $43.50 | 2022 | |
| Daiichi Sankyo INC. | $37.58 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $34.74 | 2022 | |
| Astellas Pharma US INC | $34.07 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $24.16 | 2019 | |
| Janssen Biotech, INC. | $21.26 | 2020 | |
| Clovis Oncology, INC. | $18.61 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.32 | 2020 | |
| Blue Earth Diagnostics | $18.07 | 2021 | |
| Incyte Corporation | $16.76 | 2021 | |
| Seagen INC. | $15.96 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.87 | 2021 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriya Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.